ASTRAZENECA (LSE:AZN.L)
| CAPS Rating |
|
|---|
AZN.L
VS S&P 500 (SPY)
AZN.L News and Commentary
- The Best Yielding Large Cap Healthcare Dividend Stocks – Blog at The Motley Fool
- The Cheapest Large-Capitalized Dividend Stocks With High Yields – Blog at The Motley Fool
- 10 Large Cap High Yields With Single P/E Ratio – Blog at The Motley Fool
- 7 Highly Profitable Healthcare Dividend Stocks With Great Yields – Blog at The Motley Fool
- What Shorts Might Be Watching at AstraZeneca – The Motley Fool
- 10 High Margin Healthcare Dividend Shares – Blog at The Motley Fool
- The Best Dividend Stocks for 2012 – Health Care – Blog at The Motley Fool
- The 10 Best Dividend Paying Drug Stocks – Blog at The Motley Fool
- 15 High Yield Large Caps With Best Margin – Blog at The Motley Fool
How do you think AZN.L will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
40
Outperform
5
Underperform
All-Star Players
2
Outperform
0
Underperform
Wall Street
0
Outperform
0
Underperform
RSS Headlines
Fool UK
